Full View

Ocrelizumab: a new milestone in multiple sclerosis therapy

P Mulero, L Midaglia… - Therapeutic advances in …, 2018 - journals.sagepub.com
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …
被引用次数：152 相关文章
[HTML] nih.gov

[HTML][HTML] Ocrelizumab: a new milestone in multiple sclerosis therapy

P Mulero, L Midaglia, X Montalban - Therapeutic Advances in …, 2018 - ncbi.nlm.nih.gov
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …

Ocrelizumab: a new milestone in multiple sclerosis therapy.

P Mulero, L Midaglia, X Montalban - Therapeutic Advances in …, 2018 - europepmc.org
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …

Ocrelizumab: a new milestone in multiple sclerosis therapy

P Mulero, L Midaglia… - Therapeutic advances …, 2018 - pubmed.ncbi.nlm.nih.gov
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …

Ocrelizumab: a new milestone in multiple sclerosis therapy

P Mulero, L Midaglia… - Therapeutic Advances in …, 2018 - portalrecerca.uab.cat
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …

Ocrelizumab: a new milestone in multiple sclerosis therapy.

P Mulero, L Midaglia, X Montalban - Therapeutic Advances in …, 2018 - europepmc.org
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in
the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and …